Date | Panel | Item | Activity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
COVID-19 research v0.36 | NCF2 |
Ellen McDonagh gene: NCF2 was added gene: NCF2 was added to Viral susceptibility. Sources: Expert Review Green,ESID Registry 20171117,North West GLH,Victorian Clinical Genetics Services,GRID V2.0,NHS GMS,GOSH PID v.8.0,London North GLH,IUIS Classification February 2018 Mode of inheritance for gene: NCF2 was set to BIALLELIC, autosomal or pseudoautosomal Publications for gene: NCF2 were set to 9070911; 10498624; 7795241 Phenotypes for gene: NCF2 were set to Chronic granulomatous disease due to deficiency of NCF-2 233710; Chronic granulomatous disease (CGD); Congenital defects of phagocyte number or function; Infections, autoinflammatory phenotype |